tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal has been researched along with thromboxane a2 in 1 studies
| Studies (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Trials (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Recent Studies (post-2010) (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agradi, E; Colli, S; Maderna, P; Paoletti, R; Petroni, A; Tremoli, E | 1 |
1 other study(ies) available for tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal and thromboxane a2
| Article | Year |
|---|---|
GYKI 14,451, a synthetic tripeptide inhibitor of thrombin: activity on platelet aggregation and arachidonic acid metabolism.
Topics: Arachidonic Acids; Humans; Kinetics; Malondialdehyde; Oligopeptides; Peptides; Platelet Aggregation; Thrombin; Thromboxane A2 | 1981 |